Maravai LifeSciences Holdings, Inc. MRVI Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $165.92M-23.5% | $216.89M-11.0% | $243.57M-9.8% | $269.91M-5.3% | $285.05M-11.6% | ||
| $33.42M+31.0% | $25.5M+13.1% | $22.54M-19.2% | $27.88M-2.1% | $28.49M-26.0% | ||
| $40.46M-0.1% | $40.5M-10.7% | $45.33M-2.9% | $46.67M-6.2% | $49.77M-0.6% | ||
| $12.85M-12.0% | $14.61M-8.9% | $16.03M-2.4% | $16.43M-4.5% | $17.21M+1.4% | ||
| $8.98M+22.7% | $7.32M-24.6% | $9.7M-7.8% | $10.52M+6.1% | $9.92M-1.3% | ||
| $18.63M+0.3% | $18.57M-5.2% | $19.59M-0.6% | $19.72M-13.0% | $22.65M-1.8% | ||
| $11.94M-10.7% | $13.37M-7.4% | $14.43M-5.7% | $15.31M+18.1% | $12.96M-28.6% | ||
| $251.74M-15.0% | $296.25M-9.1% | $325.87M-9.4% | $359.76M-4.4% | $376.28M-12.3% | ||
| $146.93M-3.0% | $151.48M-4.5% | $158.62M-2.5% | $162.73M-2.2% | $166.43M+1.2% | ||
| $129.43M0.0% | $129.43M0.0% | $129.43M0.0% | $129.43M-19.0% | $159.88M0.0% | ||
| $144.89M-4.4% | $151.54M-18.5% | $185.88M-3.7% | $193.07M-3.3% | $199.58M+2.4% | ||
| $40.24M-3.9% | $41.88M-15.2% | $49.4M-5.0% | $51.98M-9.7% | $57.58M-3.7% | ||
| $713.22M-7.4% | $770.58M-9.3% | $849.19M-5.3% | $896.97M-6.5% | $959.75M-4.8% | ||
| $8.54M+193% | $2.91M-63.6% | $8M-30.6% | $11.53M+21.0% | $9.53M-20.3% | ||
| $28.65M-21.7% | $36.57M+191% | $12.55M-23.7% | $16.44M-63.1% | $44.6M+12.7% | ||
| $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | ||
| $3.2M+6.7% | $3M+15.4% | $2.6M0.0% | $2.6M-25.7% | $3.5M+6.1% | ||
| $42.62M-5.1% | $44.92M-27.1% | $61.57M-11.6% | $69.68M+10.3% | $63.16M+10.9% | ||
| $235.57M-17.7% | $286.33M-0.4% | $287.38M-0.4% | $288.44M-0.4% | $289.5M-0.3% | ||
| $29.87M-0.9% | $30.14M-0.9% | $30.41M-0.8% | $30.65M-0.7% | $30.88M-0.7% | ||
| $36.07M-1.1% | $36.48M-3.9% | $37.97M-0.6% | $38.19M-13.1% | $43.97M-16.2% | ||
| $344.13M-13.5% | $397.87M-4.7% | $417.33M-2.7% | $428.98M-0.1% | $429.48M-0.4% | ||
| $202.13M+1.5% | $199.18M+1.4% | $196.51M+2.7% | $191.38M+2.5% | $186.8M+2.7% | ||
| $6.39M-36.9% | $10.12M-77.9% | $45.8M-35.8% | $71.36M-35.7% | $110.95M-21.3% | ||
| $466K-11.1% | $524K-9.5% | $579K+0.9% | $574K+77.2% | $324K— | ||
| $157.52M-1.8% | $160.33M-14.0% | $186.42M-7.8% | $202.12M-12.0% | $229.66M-8.8% | ||
| $211.56M-0.4% | $212.38M-13.5% | $245.44M-7.7% | $265.86M-11.6% | $300.61M-7.6% | ||
| $713.22M-7.4% | $770.58M-9.3% | $849.19M-5.3% | $896.97M-6.5% | $959.75M-4.8% | ||
| $18.63M+0.3% | $18.57M-5.2% | $19.59M-0.6% | $19.72M-13.0% | $22.65M-1.8% | ||
| $1.3M— | —— | $1.5M-6.3% | $1.6M-5.9% | $1.7M— | ||
| $40.24M-3.9% | $41.88M-15.2% | $49.4M-5.0% | $51.98M-9.7% | $57.58M-3.7% | ||
| $144.89M-4.4% | $151.54M-18.5% | $185.88M-3.7% | $193.07M-3.3% | $199.58M+2.4% | ||
| $40.24M-3.9% | $41.88M-15.2% | $49.4M-5.0% | $51.98M-9.7% | $57.58M-3.7% | ||
| $146.93M-3.0% | $151.48M-4.5% | $158.62M-2.5% | $162.73M-2.2% | $166.43M+1.2% | ||
| $40.24M-3.9% | $41.88M-15.2% | $49.4M-5.0% | $51.98M-9.7% | $57.58M-3.7% | ||
| $28.65M-21.7% | $36.57M-24.0% | $48.14M-4.1% | $50.2M+12.6% | $44.6M+12.7% | ||
| $28.65M-21.7% | $36.57M-24.0% | $48.14M-4.1% | $50.2M+12.6% | $44.6M+12.7% | ||
| $4.08M— | —— | $1.36M-50.0% | $2.72M-33.3% | $4.08M— | ||
| $1.3M— | —— | $1.5M-6.3% | $1.6M-5.9% | $1.7M— | ||
| $1.87M-24.3% | $2.47M-11.2% | $2.78M-9.9% | $3.08M-8.8% | $3.38M-9.8% | ||
| $270.88M-25.7% | $364.71M-0.9% | $367.94M-0.8% | $371.08M+13.6% | $326.65M-13.3% | ||
| $242.88M— | —— | $295.6M-0.5% | $296.96M-0.5% | $298.32M— | ||
| $1.1M+10.0% | $1M+150% | $400K0.0% | $400K-87.9% | $3.3M-8.3% | ||
| 6.3M— | —— | 3.3M0.0% | 3.3M— | 0— | ||
| $0— | $0— | —— | —— | —— | ||
| $3.2M+6.7% | $3M+15.4% | $2.6M0.0% | $2.6M-25.7% | $3.5M+6.1% | ||
| $242.88M— | —— | $295.6M-0.5% | $296.96M-0.5% | $298.32M— | ||
| $238.8M— | —— | $5.44M0.0% | $5.44M0.0% | $5.44M— | ||
| $4.08M— | —— | $1.36M-50.0% | $2.72M-33.3% | $4.08M— | ||
| $157.52M-1.8% | $160.33M-14.0% | $186.42M-7.8% | $202.12M-12.0% | $229.66M-8.8% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $1.1M+10.0% | $1M+150% | $400K0.0% | $400K-87.9% | $3.3M-8.3% | ||
| $4.5M— | —— | $600K-33.3% | $900K+12.5% | $800K— | ||
| $4.1M— | —— | —— | —— | —— | ||
| $4.08M— | —— | $1.36M-50.0% | $2.72M-33.3% | $4.08M— | ||
| $4.5M— | —— | $600K-33.3% | $900K+12.5% | $800K— | ||
| $400K— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Maravai LifeSciences Holdings, Inc.'s total assets?
- Maravai LifeSciences Holdings, Inc. (MRVI) holds $713.2M in total assets, down 25.7% year over year.
- How much debt does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. carries $270.9M in total debt against $211.6M of shareholders' equity, a debt-to-equity ratio of 1.28.
- How much cash does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. holds $165.9M in cash and equivalents.
- Can Maravai LifeSciences Holdings, Inc. cover its short-term obligations?
- Its current ratio is 5.91 — current assets exceed current liabilities.
- Where does Maravai LifeSciences Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
